Cellectis
CLLS
$2.99
Share price
-1.32%
Change (1 day)
71.84%
Change (1 year)
Categories
Market capitalization of Cellectis (CLLS)
Market cap: $0.21 Billion
As of May 2024 Cellectis has a market cap of $0.21 Billion. This makes Cellectis the world's 6897th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Cellectis from 2013 to 2024
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2024 | $0.21 B | -2.42% |
| 2023 | $0.22 B | 125.29% |
| 2022 | $97.86 M | -74.45% |
| 2021 | $0.38 B | -69.96% |
| 2020 | $1.27 B | 70.95% |
| 2019 | $0.74 B | 1.91% |
| 2018 | $0.73 B | -27.38% |
| 2017 | $1.00 B | 66.46% |
| 2016 | $0.60 B | -43.61% |
| 2015 | $1.07 B | 145.21% |
| 2014 | $0.43 B | 554.04% |
| 2013 | $66.95 M |
End of Day market cap according to different sources
On May 19th, 2024 the market cap of Cellectis was reported to be:
$0.21 Billion
$0.21 Billion
$0.21 Billion
$0.21 Billion
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Regeneron Pharmaceuticals REGN | $108.23 B | 50,207.29% | 🇺🇸 USA |
 uniQure QURE | $0.24 B | 13.05% | 🇳🇱 Netherlands |
 Novavax NVAX | $1.91 B | 790.72% | 🇺🇸 USA |
 Flexion Therapeutics
FLXN | $0.45 B | 113.31% | 🇺🇸 USA |